First batch of CREMA students placed in the industry

Clinical Research Education&Management Academy (CREMA) recently announced that 70 per cent of its students from the first batch of advanced post-graduate diploma in clinical research (APGDCR) and post-graduate diploma in clinical research (PGDCR) have been offered placements in the industry, even before the completion of their courses. Companies like Piramal Life Sciences, Sun Pharma, TCS, Cognizant, Novartis, Quintiles and Sanofi Aventis have recruited CREMA's students.

"Two-thirds of our students being absorbed by the industry even before their convocation, is a testimony to the fact that the education at CREMA is of the superior class and up-to-date with the needs of the industry. It also throws light on the huge demand in the industry today for an adequately trained clinical research professionals," said Vijay Moza, chairman, CREMA.

"Unlike other industries in general, the clinical research industry in India is absolutely recession-proof, as there is a lot of demand for trained clinical research professionals. In the next three years, this demand is estimated to grow five times to touch 50,000 from the present 10, 000," informed Dr S M Sapatnekar, dean, CREMA.

Recently, India surpassed China to become Asia's most popular destination for conducting clinical trials. According to the planning commission, 139 new trials were outsourced to India in the recent past, as opposed to 98 in China.